“`html
Investors are increasingly interested in the cannabis market, valued at $43.72 billion in 2022 and projected to reach $444.34 billion by 2030, reflecting a CAGR of 34.03%. Key players include Tilray Brands (TLRY) and Cresco Labs (CRLBF). Over the past six months, Tilray’s shares surged by 105.5%, while Cresco’s gained only 0.3%.
In its fiscal first quarter, Tilray reported Canadian cannabis revenues of $51 million, a 4% year-over-year increase, leveraging approximately 5 million square feet of cultivation space. Conversely, Cresco Labs launched its flagship flower in Germany, entering one of the fastest-growing cannabis markets. While Cresco holds leading shares in limited-license states like Illinois and Ohio, its revenues have declined year over year due to increasing domestic pricing pressures.
Tilray is currently trading at a forward price-to-sales ratio of 1.21, above its median of 0.99, while Cresco’s is 0.38, below its one-year median of 0.58. For fiscal 2026, Tilray expects a loss per share of 5 cents, compared to Cresco’s projected loss of 14 cents for 2025.
“`
